Quest Diagnostics Incorporated Stock Performance
| DGX Stock | USD 202.44 1.95 0.95% |
Quest Diagnostics has a performance score of 5 on a scale of 0 to 100. The company holds a Beta of 0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, Quest Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Quest Diagnostics is expected to be smaller as well. Quest Diagnostics right now holds a risk of 1.68%. Please check Quest Diagnostics standard deviation, expected short fall, relative strength index, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Quest Diagnostics will be following its historical price patterns.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Quest Diagnostics Incorporated are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, Quest Diagnostics may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return (0.95) | Five Day Return (2.43) | Year To Date Return 16.49 | Ten Year Return 205.29 | All Time Return 5.7 K |
Forward Dividend Yield 0.0168 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 3.44 | Dividend Date 2026-04-20 |
1 | Data Featuring Haystack MRD from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium | 01/06/2026 |
2 | Nordea Investment Management AB Trims Holdings in Quest Diagnostics Incorporated DGX - MarketBeat | 01/16/2026 |
| Quest Diagnostics dividend paid on 28th of January 2026 | 01/28/2026 |
3 | A Look At Quest Diagnostics Valuation After Barclays Upgrade And Earnings Growth Optimism | 02/02/2026 |
4 | Why Is Quest Stock Soaring Today | 02/10/2026 |
5 | Mystic Aquarium makes splashy Stonington buy, but plans remain a mystery | 02/11/2026 |
6 | Quest Diagnostics Testing Volume Growth Tracks SP 500 | 02/12/2026 |
7 | Quest Diagnostics Incorporated DGX Shares Sold by Cookson Peirce Co. Inc. | 02/13/2026 |
8 | Labcorp forecasts upbeat annual profit on strong demand for diagnostic products | 02/17/2026 |
9 | Should semen analysis become the Pap smear for men Some mens health experts say yes | 02/19/2026 |
| Begin Period Cash Flow | 549 M | |
| Total Cashflows From Investing Activities | -631 M |
Quest Diagnostics Relative Risk vs. Return Landscape
If you would invest 18,971 in Quest Diagnostics Incorporated on November 22, 2025 and sell it today you would earn a total of 1,273 from holding Quest Diagnostics Incorporated or generate 6.71% return on investment over 90 days. Quest Diagnostics Incorporated is generating 0.1238% of daily returns assuming volatility of 1.6824% on return distribution over 90 days investment horizon. In other words, 15% of stocks are less volatile than Quest, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Quest Diagnostics Target Price Odds to finish over Current Price
The tendency of Quest Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 202.44 | 90 days | 202.44 | roughly 2.55 |
Based on a normal probability distribution, the odds of Quest Diagnostics to move above the current price in 90 days from now is roughly 2.55 (This Quest Diagnostics Incorporated probability density function shows the probability of Quest Stock to fall within a particular range of prices over 90 days) .
Quest Diagnostics Price Density |
| Price |
Predictive Modules for Quest Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Quest Diagnostics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Quest Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Quest Diagnostics is not an exception. The market had few large corrections towards the Quest Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Quest Diagnostics Incorporated, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Quest Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.12 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 9.07 | |
Ir | Information ratio | 0.04 |
Quest Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quest Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quest Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Quest Diagnostics has a strong financial position based on the latest SEC filings | |
| On 28th of January 2026 Quest Diagnostics paid $ 0.8 per share dividend to its current shareholders | |
| Latest headline from statnews.com: Should semen analysis become the Pap smear for men Some mens health experts say yes |
Quest Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quest Stock often depends not only on the future outlook of the current and potential Quest Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 113 M | |
| Cash And Short Term Investments | 420 M |
Quest Diagnostics Fundamentals Growth
Quest Stock prices reflect investors' perceptions of the future prospects and financial health of Quest Diagnostics, and Quest Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Quest Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0641 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 28.28 B | ||||
| Shares Outstanding | 110.24 M | ||||
| Price To Earning | 14.57 X | ||||
| Price To Book | 3.11 X | ||||
| Price To Sales | 2.04 X | ||||
| Revenue | 11.04 B | ||||
| Gross Profit | 3.68 B | ||||
| EBITDA | 2.15 B | ||||
| Net Income | 1.05 B | ||||
| Cash And Equivalents | 420 M | ||||
| Cash Per Share | 6.15 X | ||||
| Total Debt | 6.92 B | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 65.18 X | ||||
| Cash Flow From Operations | 1.89 B | ||||
| Earnings Per Share | 8.66 X | ||||
| Market Capitalization | 22.52 B | ||||
| Total Asset | 16.23 B | ||||
| Retained Earnings | 9.99 B | ||||
| Working Capital | 223 M | ||||
| Current Asset | 1.5 B | ||||
| Current Liabilities | 1.17 B | ||||
About Quest Diagnostics Performance
Evaluating Quest Diagnostics' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Quest Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Quest Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 9.18 | 10.25 | |
| Return On Tangible Assets | 0.18 | 0.14 | |
| Return On Capital Employed | 0.11 | 0.10 | |
| Return On Assets | 0.06 | 0.04 | |
| Return On Equity | 0.14 | 0.08 |
Things to note about Quest Diagnostics performance evaluation
Checking the ongoing alerts about Quest Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Quest Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Quest Diagnostics has a strong financial position based on the latest SEC filings | |
| On 28th of January 2026 Quest Diagnostics paid $ 0.8 per share dividend to its current shareholders | |
| Latest headline from statnews.com: Should semen analysis become the Pap smear for men Some mens health experts say yes |
- Analyzing Quest Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Quest Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Quest Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Quest Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Quest Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Quest Diagnostics' stock. These opinions can provide insight into Quest Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.